Principal Engineer, R&D Software Engineering

India

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Clinical Trial Technology, Healthcare TechnologyIndustries

Requirements

Candidates must possess a Bachelor's degree in Computer Science, Engineering, or equivalent practical experience, along with at least 10 years of enterprise software development experience. Hands-on experience with Azure and/or AWS cloud platforms, including Azure Data Factory, Logic Apps, Functions, Storage, Azure SQL, and AWS Lambda, CloudWatch, S3, SNS/SQS, DynamoDB, RDS is essential. Deep expertise in Infrastructure as Code tools such as Terraform, Bicep, ARM templates, and CloudFormation is required, as is a strong understanding of data modeling, database design, and process modeling. Familiarity with DevOps pipelines, CI/CD tools, cloud-native patterns, modern software engineering frameworks, agile development practices, excellent communication, and cross-team collaboration skills are also necessary. Demonstrated leadership in technical decision-making and mentoring teams is a must.

Responsibilities

The Principal Engineer, R&D Software Engineering will design, develop, test, debug, and implement cloud-native software programs using Azure and AWS services, architecting robust, secure, and scalable solutions. They will lead Infrastructure as Code implementation, define and enforce engineering standards for coding, architecture, performance, and cloud security. This role involves providing technical leadership through mentorship, hands-on coding, code reviews, and technical strategy, while collaborating with cross-functional teams to ensure data compliance, operational excellence, and innovation. Responsibilities also include supporting DevOps practices like CI/CD pipelines, cloud monitoring, and security automation, prototyping new ideas for product innovation, and sharing cloud architectural best practices.

Skills

Azure

AWS

Cloud-native software development

Azure Data Factory

Azure Logic Apps

Azure Functions

Azure Storage

Azure SQL

AWS Lambda

AWS S3

AWS SNS/SQS

AWS RDS

Terraform

Bicep

ARM templates

AWS CloudFormation

Infrastructure as Code (IaC)

Cloud security

DevOps

CI/CD pipelines

Cloud monitoring

Security automation

DynamoDB

CloudWatch

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free